One-year efficacy and safety of prasugrel and ticagrelor in patients with acute coronary syndromes: Results from a prospective and multicentre ACHILLES registry.

ABSTRACT:

Background

Prasugrel and ticagrelor have demonstrated higher efficacy than clopidogrel in their main clinical trials for patients with acute coronary syndrome (ACS). However, the long-term prognosis and different clinical characteristics related to the type of antiplatelet prescription in current clinical practice ACS patients have not been analysed in depth. The objective of this study was to analyse the clinical profile of ACS and the efficacy and safety of novel oral P2Y₁₂ inhibitors in current clinical practice patients discharged afterACS.

Methods

We collected data from the ACHILLES registry, and an observational, prospective and multicentre registry of patients discharged after ACS. We analysed baseline characteristics, clinical profile and therapy during AC

SUBMITTER: Ruiz-Nodar JM 

PROVIDER: S-EPMC7256120 | biostudies-literature | 2020 Jun

REPOSITORIES: biostudies-literature